Oracle (ORCL) Stock Forecast, Price Target & Predictions
ORCL Stock Forecast
Oracle stock forecast is as follows: an average price target of $184.18 (represents a 8.56% upside from ORCL’s last price of $169.66) and a rating consensus of 'Buy', based on 33 wall street analysts offering a 1-year stock forecast.
ORCL Price Target
The average price target for Oracle (ORCL) is $184.18 based on 1-year price targets from 33 Wall Street analysts in the past 3 months, with a price target range of $220.00 to $155.00. This represents a potential 8.56% upside from ORCL's last price of $169.66.
ORCL Analyst Ratings
Buy
According to 33 Wall Street analysts, Oracle's rating consensus is 'Buy'. The analyst rating breakdown for ORCL stock is 0 'Strong Buy' (0.00%), 23 'Buy' (69.70%), 10 'Hold' (30.30%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Oracle Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Dec 11, 2024 | Joseph Bonner | Argus Research | $200.00 | $178.58 | 11.99% | 17.88% |
| Dec 10, 2024 | Karl Keirstead | UBS | $210.00 | $177.74 | 18.15% | 23.78% |
| Dec 05, 2024 | John DiFucci | Guggenheim | $220.00 | $187.52 | 17.32% | 29.67% |
| Oct 23, 2024 | Rishi Jaluria | RBC Capital | $165.00 | $175.31 | -5.88% | -2.75% |
| Sep 16, 2024 | Stephen Bersey | HSBC | $210.00 | $170.11 | 23.45% | 23.78% |
| Sep 15, 2024 | Brent Thill | Jefferies | $190.00 | $162.03 | 17.26% | 11.99% |
| Sep 13, 2024 | Brent Bracelin | Piper Sandler | $185.00 | $164.56 | 12.42% | 9.04% |
| Sep 13, 2024 | Tyler Radke | Citigroup | $157.00 | $161.38 | -2.71% | -7.46% |
| Sep 13, 2024 | Brad Zelnick | Deutsche Bank | $200.00 | $161.38 | 23.93% | 17.88% |
| Sep 13, 2024 | Kirk Materne | Evercore ISI | $190.00 | $161.38 | 17.73% | 11.99% |
| Sep 13, 2024 | Jackson Ader | KeyBanc | $190.00 | $161.38 | 17.73% | 11.99% |
| Sep 13, 2024 | Karl Keirstead | UBS | $200.00 | $161.38 | 23.93% | 17.88% |
| Sep 10, 2024 | Patrick Walravens | JMP Securities | $175.00 | $156.59 | 11.76% | 3.15% |
| Sep 10, 2024 | Silvan Tuerkcan | JMP Securities | $80.00 | $156.38 | -48.84% | -52.85% |
| Sep 10, 2024 | Keith Bachman | BMO Capital | $173.00 | $156.80 | 10.33% | 1.97% |
| Sep 10, 2024 | Brent Bracelin | Piper Sandler | $175.00 | $156.82 | 11.59% | 3.15% |
| Sep 10, 2024 | Brad Reback | Stifel Nicolaus | $155.00 | $156.47 | -0.94% | -8.64% |
| Sep 10, 2024 | Ben Reitzes | Melius Research | $155.00 | $156.64 | -1.05% | -8.64% |
| Sep 10, 2024 | Siti Panigrahi | Mizuho Securities | $185.00 | $155.89 | 18.67% | 9.04% |
| Sep 10, 2024 | Jackson Ader | KeyBanc | $175.00 | $156.52 | 11.81% | 3.15% |
| Sep 09, 2024 | Keith Bachman | BMO Capital | $160.00 | $142.34 | 12.41% | -5.69% |
| Sep 03, 2024 | Mark Moerdler | Bernstein | $171.00 | $141.55 | 20.81% | 0.79% |
| Jul 09, 2024 | Brent Thill | Jefferies | $150.00 | $140.68 | 6.62% | -11.59% |
| Jun 18, 2024 | Joseph Bonner | Argus Research | $159.00 | $141.31 | 12.52% | -6.28% |
| Jun 17, 2024 | Siti Panigrahi | Mizuho Securities | $170.00 | $139.33 | 22.01% | 0.20% |
| Jun 12, 2024 | Brent Bracelin | Piper Sandler | $150.00 | $123.88 | 21.08% | -11.59% |
| Jun 12, 2024 | Keith Weiss | Morgan Stanley | $125.00 | $123.88 | 0.90% | -26.32% |
| Jun 12, 2024 | Raimo Lenschow | Barclays | $160.00 | $139.64 | 14.58% | -5.69% |
| Jun 12, 2024 | Brad Reback | Stifel Nicolaus | $135.00 | $123.88 | 8.98% | -20.43% |
| Jun 12, 2024 | Angelo Zino | CFRA | $150.00 | $123.88 | 21.08% | -11.59% |
| Jun 12, 2024 | Brad Zelnick | Deutsche Bank | $150.00 | $123.88 | 21.08% | -11.59% |
| Jun 12, 2024 | Kirk Materne | Evercore ISI | $160.00 | $123.88 | 29.16% | -5.69% |
| Jun 12, 2024 | Gil Luria | D.A. Davidson | $105.00 | $123.88 | -15.24% | -38.11% |
| Jun 12, 2024 | Jackson Ader | KeyBanc | $165.00 | $139.15 | 18.58% | -2.75% |
| Jun 10, 2024 | Keith Weiss | Morgan Stanley | $155.00 | $124.50 | 24.50% | -8.64% |
| Jun 10, 2024 | Raimo Lenschow | Barclays | $147.00 | $124.50 | 18.07% | -13.36% |
| Jun 06, 2024 | Keith Bachman | BMO Capital | $142.00 | $123.67 | 14.82% | -16.30% |
| Apr 22, 2024 | Karl Keirstead | UBS | $150.00 | $114.53 | 30.97% | -11.59% |
| Mar 20, 2024 | Jackson Ader | KeyBanc | $150.00 | $129.24 | 16.06% | -11.59% |
| Mar 14, 2024 | Joseph Bonner | Argus Research | $145.00 | $125.53 | 15.51% | -14.53% |
| Mar 13, 2024 | Stephen Bersey | HSBC | $152.00 | $125.52 | 21.10% | -10.41% |
| Mar 12, 2024 | Brent Bracelin | Piper Sandler | $140.00 | $127.54 | 9.77% | -17.48% |
| Mar 12, 2024 | Angelo Zino | CFRA | $142.00 | $127.54 | 11.34% | -16.30% |
| Mar 12, 2024 | Brad Reback | Stifel Nicolaus | $120.00 | $127.54 | -5.91% | -29.27% |
| Mar 12, 2024 | Siti Panigrahi | Mizuho Securities | $160.00 | $127.54 | 25.45% | -5.69% |
| Dec 08, 2023 | Tyler Radke | Citigroup | $120.00 | $112.87 | 6.32% | -29.27% |
| Dec 08, 2023 | Nay Soe Naing | Berenberg Bank | $110.00 | $112.87 | -2.54% | -35.16% |
| Dec 08, 2023 | Keith Weiss | Morgan Stanley | $107.00 | $112.87 | -5.20% | -36.93% |
| Dec 07, 2023 | Siti Panigrahi | Mizuho Securities | $150.00 | $112.30 | 33.57% | -11.59% |
| Sep 22, 2023 | John DiFucci | Guggenheim | $150.00 | $109.03 | 37.58% | -11.59% |
| Sep 11, 2023 | Brent Thill | Jefferies | $145.00 | $126.31 | 14.79% | -14.53% |
| Aug 28, 2023 | Karl Keirstead | UBS | $140.00 | $116.84 | 19.82% | -17.48% |
| Jun 13, 2023 | Keith Weiss | Morgan Stanley | $105.00 | $118.03 | -11.04% | -38.11% |
| Jun 13, 2023 | Kash Rangan | Goldman Sachs | $120.00 | $116.43 | 3.07% | -29.27% |
| Jun 12, 2023 | Alex Zukin | Wolfe Research | $130.00 | $109.85 | 18.34% | -23.38% |
| Jun 09, 2023 | Karl Keirstead | UBS | $110.00 | $107.48 | 2.34% | -35.16% |
| Jun 09, 2023 | Mark Murphy | J.P. Morgan | $93.00 | $107.48 | -13.47% | -45.18% |
| Jun 09, 2023 | Brad Zelnick | Deutsche Bank | $120.00 | $107.48 | 11.65% | -29.27% |
| Jun 09, 2023 | Brent Bracelin | Piper Sandler | $130.00 | $107.48 | 20.95% | -23.38% |
| Mar 10, 2023 | Siti Panigrahi | Mizuho Securities | $116.00 | $83.87 | 38.31% | -31.63% |
| Jan 09, 2023 | Piper Sandler | $104.00 | $85.66 | 21.41% | -38.70% | |
| Jan 05, 2023 | Jefferies | $105.00 | $84.62 | 24.08% | -38.11% | |
| Dec 13, 2022 | John DiFucci | Guggenheim | $115.00 | $82.25 | 39.81% | -32.22% |
| Dec 13, 2022 | Cowen & Co. | $96.00 | $83.01 | 15.65% | -43.42% | |
| Dec 13, 2022 | Piper Sandler | $85.00 | $81.28 | 4.58% | -49.90% | |
| Dec 05, 2022 | Barclays | $81.00 | $83.35 | -2.82% | -52.26% | |
| Sep 13, 2022 | Keith Weiss | Morgan Stanley | $90.00 | $77.20 | 16.58% | -46.95% |
| Sep 13, 2022 | Brent Thill | Jefferies | $85.00 | $77.08 | 10.28% | -49.90% |
| Sep 13, 2022 | Brent Bracelin | Piper Sandler | $70.00 | $77.08 | -9.19% | -58.74% |
| Sep 13, 2022 | Kirk Materne | Evercore ISI | $87.00 | $76.04 | 14.41% | -48.72% |
| Sep 13, 2022 | Keith Bachman | BMO Capital | $90.00 | $76.04 | 18.36% | -46.95% |
| Jul 21, 2022 | Phil Winslow's | Credit Suisse | $115.00 | $73.83 | 55.77% | -32.22% |
| Jul 04, 2022 | Stefan Slowinski | BNP Paribas | $90.00 | $70.87 | 26.99% | -46.95% |
| Jun 14, 2022 | Brad Reback | Stifel Nicolaus | $72.00 | $64.05 | 12.41% | -57.56% |
| Jun 14, 2022 | Brent Thill | Jefferies | $80.00 | $70.72 | 13.12% | -52.85% |
| Jun 13, 2022 | Tyler Radke | Citigroup | $75.00 | $64.05 | 17.10% | -55.79% |
| Jun 13, 2022 | Keith Weiss | Morgan Stanley | $88.00 | $64.05 | 37.39% | -48.13% |
| Jun 10, 2022 | Kirk Materne | Evercore ISI | $88.00 | $67.14 | 31.07% | -48.13% |
| Jun 09, 2022 | Derrick Wood | Cowen & Co. | $98.00 | $69.22 | 41.58% | -42.24% |
| Jun 07, 2022 | Raimo Lenschow | Barclays | $82.00 | $72.69 | 12.81% | -51.67% |
| Jun 06, 2022 | Keith Weiss | Morgan Stanley | $88.00 | $73.07 | 20.43% | -48.13% |
| Jun 06, 2022 | Brian White | Monness | $126.00 | $72.97 | 72.67% | -25.73% |
| May 23, 2022 | Brent Thill | Jefferies | $75.00 | $69.94 | 7.24% | -55.79% |
| Mar 11, 2022 | Keith Bachman | BMO Capital | $92.00 | $77.52 | 18.68% | -45.77% |
| Mar 11, 2022 | Kirk Materne | Evercore ISI | $88.00 | $77.52 | 13.52% | -48.13% |
| Mar 11, 2022 | Alex Zukin | Wolfe Research | $83.00 | $77.82 | 6.66% | -51.08% |
| Mar 11, 2022 | Bradley Sills | Bank of America Securities | $90.00 | $77.52 | 16.10% | -46.95% |
| Mar 11, 2022 | Richard Nguyen | Societe Generale | $98.00 | $77.52 | 26.42% | -42.24% |
| Mar 09, 2022 | Brent Thill | Jefferies | $80.00 | $75.80 | 5.54% | -52.85% |
| Mar 09, 2022 | Derrick Wood | Cowen & Co. | $100.00 | $75.80 | 31.93% | -41.06% |
| Mar 08, 2022 | Karl Keirstead | UBS | $75.00 | $73.04 | 2.68% | -55.79% |
| Mar 08, 2022 | Brad Zelnick | Deutsche Bank | $110.00 | $73.04 | 50.60% | -35.16% |
| Dec 15, 2021 | Ingo Wermann | DZ BANK AG | $105.00 | $102.86 | 2.08% | -38.11% |
| Dec 13, 2021 | Tyler Radke | Citigroup | $100.00 | $100.12 | -0.12% | -41.06% |
| Sep 20, 2021 | Keith Weiss | Morgan Stanley | $87.00 | $85.22 | 2.09% | -48.72% |
| Sep 14, 2021 | Kash Rangan | Goldman Sachs | $66.00 | $85.44 | -22.75% | -61.10% |
The latest Oracle stock forecast, released on Dec 11, 2024 by Joseph Bonner from Argus Research, set a price target of $200.00, which represents a 11.99% increase from the stock price at the time of the forecast ($178.58), and a 17.88% increase from ORCL last price ($169.66).
Oracle Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 3 | 4 | 45 |
| Avg Price Target | $210.00 | $198.75 | $162.29 |
| Last Closing Price | $169.66 | $169.66 | $169.66 |
| Upside/Downside | 23.78% | 17.15% | -4.34% |
In the current month, the average price target of Oracle stock is $210.00, according to 3 Wall Street analysts offering twelve months forecast. The average price target represents a 23.78% increase as opposed to Oracle's last price of $169.66. This month's average price target is up 5.66% compared to last quarter, and up 29.40% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 10, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
| Dec 10, 2024 | UBS | Buy | Buy | Hold |
| Dec 10, 2024 | Barclays | Overweight | Overweight | Hold |
| Dec 10, 2024 | Citigroup | Neutral | Neutral | Hold |
| Dec 10, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Dec 09, 2024 | RBC Capital | Sector Perform | Sector Perform | Initialise |
| Dec 09, 2024 | JMP Securities | Market Outperform | Market Outperform | Hold |
| Dec 09, 2024 | Jefferies | Buy | Buy | Hold |
| Dec 09, 2024 | Bernstein | Outperform | Outperform | Hold |
| Dec 05, 2024 | Guggenheim | Buy | Buy | Hold |
| Oct 23, 2024 | RBC Capital | Sector Perform | Initialise | |
| Oct 18, 2024 | UBS | Market Outperform | Market Outperform | Hold |
| Oct 18, 2024 | JMP Securities | Outperform | Outperform | Hold |
| Oct 14, 2024 | Morgan Stanley | Outperform | Outperform | Hold |
| Sep 30, 2024 | Bernstein | Outperform | Outperform | Hold |
| Sep 16, 2024 | HSBC | Buy | Buy | Hold |
| Sep 13, 2024 | JMP Securities | Market Outperform | Market Outperform | Hold |
| Sep 13, 2024 | Guggenheim | Buy | Buy | Hold |
| Sep 13, 2024 | UBS | Buy | Buy | Hold |
| Sep 11, 2024 | Citigroup | Neutral | Neutral | Hold |
| Sep 10, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
| Sep 10, 2024 | JMP Securities | Outperform | Market Outperform | Upgrade |
| Sep 10, 2024 | CFRA | Hold | Hold | Hold |
| Sep 10, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Sep 10, 2024 | William Blair | Outperform | Outperform | Hold |
| Sep 10, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Sep 10, 2024 | Oppenheimer | Perform | Perform | Hold |
| Sep 10, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Sep 10, 2024 | Barclays | Overweight | Overweight | Hold |
| Sep 10, 2024 | JMP Securities | Market Perform | Outperform | Upgrade |
| Sep 10, 2024 | Citigroup | Neutral | Market Outperform | Upgrade |
| Sep 09, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Sep 09, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Sep 09, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| Sep 09, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Sep 05, 2024 | Jefferies | Buy | Buy | Hold |
| Sep 03, 2024 | Bernstein | Outperform | Outperform | Hold |
| Jul 12, 2024 | UBS | Market Perform | Market Perform | Hold |
| Jul 09, 2024 | Jefferies | Buy | Buy | Hold |
| Jun 17, 2024 | UBS | Market Perform | Market Perform | Hold |
| Jun 12, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
| Jun 12, 2024 | JMP Securities | Market Perform | Market Perform | Hold |
| Jun 12, 2024 | Needham | Buy | Buy | Hold |
| Jun 12, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| Jun 12, 2024 | Citigroup | Neutral | Neutral | Hold |
| Jun 12, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Jun 12, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Jun 12, 2024 | Bernstein | Outperform | Outperform | Hold |
| Jun 12, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
| Jun 12, 2024 | CFRA | Hold | Hold | Hold |
| Jun 12, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Jun 12, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Jun 10, 2024 | Barclays | Overweight | Overweight | Hold |
| Jun 10, 2024 | UBS | Buy | Buy | Hold |
| Jun 10, 2024 | Cowen & Co. | Outperform | Outperform | Hold |
| Jun 10, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jun 10, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Jun 06, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| Apr 22, 2024 | UBS | Buy | Buy | Hold |
| Apr 17, 2024 | Oppenheimer | Perform | Initialise | |
| Mar 12, 2024 | Barclays | Overweight | Overweight | Hold |
| Mar 12, 2024 | William Blair | Market Perform | Outperform | Upgrade |
| Mar 08, 2024 | Wolfe Research | Outperform | Outperform | Hold |
| Mar 08, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| Mar 08, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Mar 08, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Dec 12, 2023 | William Blair | Market Perform | Market Perform | Hold |
| Dec 12, 2023 | Wolfe Research | Outperform | Outperform | Hold |
| Dec 12, 2023 | UBS | Buy | Buy | Hold |
| Dec 08, 2023 | Piper Sandler | Overweight | Overweight | Hold |
| Dec 08, 2023 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Dec 08, 2023 | BMO Capital | Market Perform | Market Perform | Hold |
| Dec 08, 2023 | Citigroup | Neutral | Neutral | Hold |
| Oct 09, 2023 | Evercore ISI | Outperform | Upgrade | |
| Sep 22, 2023 | Guggenheim | Buy | Buy | Hold |
| Sep 22, 2023 | Goldman Sachs | Neutral | Neutral | Hold |
| Sep 21, 2023 | Needham | Hold | Hold | Hold |
| Sep 14, 2023 | BMO Capital | Perform | Outperform | Upgrade |
| Sep 14, 2023 | Redburn Partners | Buy | Upgrade | |
| Sep 14, 2023 | Citigroup | Buy | Upgrade | |
| Sep 14, 2023 | Summit Insights Group | Buy | Upgrade | |
| Sep 14, 2023 | Scotiabank | Outperform | Upgrade | |
| Sep 14, 2023 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| Sep 14, 2023 | Jefferies | Buy | Hold | Downgrade |
| Sep 14, 2023 | Benchmark | Hold | Downgrade | |
| Sep 12, 2023 | UBS | Buy | Buy | Hold |
| Sep 11, 2023 | Jefferies | Buy | Buy | Hold |
| Sep 11, 2023 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Sep 11, 2023 | Piper Sandler | Overweight | Overweight | Hold |
| Sep 05, 2023 | Barclays | Equal-Weight | Overweight | Upgrade |
| Aug 28, 2023 | UBS | Neutral | Buy | Upgrade |
| Aug 16, 2023 | Piper Sandler | Overweight | Overweight | Hold |
| Jun 13, 2023 | Cowen & Co. | Outperform | Outperform | Hold |
| Jun 13, 2023 | William Blair | Market Perform | Market Perform | Hold |
| Jun 13, 2023 | HSBC | Buy | Upgrade | |
| Jun 13, 2023 | Canaccord Genuity | Buy | Initialise | |
| Jun 13, 2023 | Keefe, Bruyette & Woods | Market Perform | Downgrade | |
| Jun 13, 2023 | BMO Capital | Market Perform | Perform | Downgrade |
| Jun 13, 2023 | CJS Securities | Perform | Downgrade | |
| Jun 13, 2023 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| Jun 13, 2023 | Goldman Sachs | Buy | Neutral | Upgrade |
| Jun 13, 2023 | Guggenheim | Buy | Buy | Hold |
| Jun 13, 2023 | BMO Capital | Market Perform | Market Perform | Hold |
| Jun 12, 2023 | Wolfe Research | Outperform | Upgrade | |
| Jun 09, 2023 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Jun 09, 2023 | Jefferies | Buy | Buy | Hold |
| Jun 09, 2023 | UBS | Neutral | Neutral | Hold |
| Jun 09, 2023 | Deutsche Bank | Buy | Buy | Hold |
| Jun 09, 2023 | Piper Sandler | Overweight | Overweight | Hold |
| Mar 10, 2023 | Mizuho Securities | Buy | Buy | Hold |
| Mar 10, 2023 | BMO Capital | Perform | Perform | Hold |
| Jan 09, 2023 | Piper Sandler | Hold | Overweight | Upgrade |
| Jan 05, 2023 | Jefferies | Hold | Buy | Upgrade |
| Dec 19, 2022 | Deutsche Bank | Buy | Buy | Hold |
| Dec 13, 2022 | Piper Sandler | Hold | Hold | Hold |
| Dec 13, 2022 | Guggenheim | Buy | Buy | Hold |
| Dec 13, 2022 | Cowen & Co. | Outperform | Outperform | Hold |
| Dec 13, 2022 | Piper Sandler | Neutral | Neutral | Hold |
| Dec 11, 2022 | Jefferies | Hold | Hold | Hold |
| Dec 05, 2022 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Oct 21, 2022 | Piper Sandler | Neutral | Neutral | Hold |
| Oct 21, 2022 | Jefferies | Hold | Hold | Hold |
| Oct 21, 2022 | Deutsche Bank | Buy | Buy | Hold |
| Oct 21, 2022 | KeyBanc | Overweight | Upgrade | |
| Oct 19, 2022 | Piper Sandler | Neutral | Upgrade | |
| Sep 13, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Sep 13, 2022 | Jefferies | Overweight | Overweight | Hold |
| Sep 13, 2022 | BMO Capital | Market Perform | Market Perform | Hold |
| Jun 29, 2022 | Exane BNP Paribas | Outperform | Upgrade | |
| Jun 28, 2022 | Daiwa | Neutral | Neutral | Hold |
| Jun 27, 2022 | Goldman Sachs | Buy | Upgrade | |
| Jun 18, 2022 | Deutsche Bank | Buy | Buy | Hold |
| Jun 13, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| May 23, 2022 | Jefferies | Hold | Hold | Hold |
| Mar 13, 2022 | Societe Generale | Buy | Upgrade | |
| Jan 30, 2022 | Deutsche Bank | Buy | Buy | Hold |
| Dec 26, 2021 | Deutsche Bank | Buy | Buy | Hold |
| Dec 11, 2021 | Deutsche Bank | Buy | Upgrade | |
| Mar 07, 2021 | Barclays | Overweight | Upgrade |
Oracle's last stock rating was published by Goldman Sachs on Dec 10, 2024. The company gave ORCL a "Neutral" rating, the same as its previous rate.
Oracle Financial Forecast
Oracle Revenue Forecast
Quarter
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Nov 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.45B | $13.84B | - | $12.28B | $11.45B | $11.84B | - | - | $9.73B | $11.23B | - | - | $9.37B | $10.44B | - |
| Avg Forecast | $20.15B | $18.37B | $17.73B | $16.53B | $17.71B | $16.13B | $15.76B | $14.92B | $15.91B | $14.38B | $14.12B | $13.23B | $14.56B | $13.29B | $13.05B | $12.48B | $13.74B | $12.43B | $11.56B | $11.33B | $11.61B | $10.51B | $10.20B | $9.76B | $11.02B | $10.07B | $9.77B | $9.17B | $10.61B | $9.75B |
| High Forecast | $20.36B | $18.56B | $17.92B | $16.70B | $17.89B | $16.30B | $15.93B | $15.07B | $16.08B | $14.49B | $14.32B | $13.24B | $14.56B | $13.29B | $13.15B | $12.61B | $13.88B | $12.56B | $13.87B | $11.44B | $11.72B | $10.61B | $10.31B | $9.85B | $11.12B | $10.17B | $9.87B | $9.26B | $10.72B | $9.84B |
| Low Forecast | $20.06B | $18.29B | $17.66B | $16.45B | $17.63B | $16.06B | $15.69B | $14.85B | $15.85B | $14.32B | $14.05B | $13.23B | $14.56B | $13.29B | $13.01B | $12.42B | $13.68B | $12.37B | $9.25B | $11.17B | $11.45B | $10.36B | $10.06B | $9.62B | $10.86B | $9.93B | $9.64B | $9.04B | $10.46B | $9.61B |
| # Analysts | 8 | 8 | 9 | 13 | 8 | 8 | 8 | 12 | 7 | 16 | 17 | 8 | 9 | 9 | 15 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 10 | 10 | 10 | 8 | 10 | 14 | 8 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.01% | - | 1.06% | 1.01% | 1.02% | - | - | 1.00% | 1.02% | - | - | 1.02% | 0.98% | - |
Forecast
Oracle's average Quarter revenue forecast for Nov 23 based on 15 analysts is $13.05B, with a low forecast of $13.01B, and a high forecast of $13.15B. ORCL's average Quarter revenue forecast represents a 4.82% increase compared to the company's last Quarter revenue of $12.45B (Aug 23).
Oracle EBITDA Forecast
Quarter
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Nov 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 8 | 9 | 13 | 8 | 8 | 8 | 12 | 7 | 16 | 17 | 8 | 9 | 9 | 15 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 10 | 10 | 10 | 8 | 10 | 14 | 8 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.30B | $6.53B | - | $4.56B | $4.09B | $5.26B | - | - | $4.14B | $5.61B | - | - | $3.91B | $5.00B | - |
| Avg Forecast | $8.58B | $7.82B | $7.55B | $7.04B | $7.54B | $6.87B | $6.71B | $6.35B | $6.78B | $6.13B | $6.01B | $5.64B | $6.20B | $5.40B | $5.56B | $5.31B | $5.85B | $4.91B | $-58.05M | $4.83B | $4.95B | $4.46B | $4.35B | $4.16B | $4.70B | $4.39B | $4.17B | $3.91B | $4.52B | $4.24B |
| High Forecast | $8.67B | $7.91B | $7.63B | $7.11B | $7.62B | $6.94B | $6.78B | $6.42B | $6.85B | $6.17B | $6.10B | $5.64B | $6.20B | $6.48B | $5.60B | $5.37B | $5.91B | $5.89B | $-46.44M | $4.88B | $5.00B | $5.36B | $4.39B | $4.20B | $4.74B | $5.26B | $4.21B | $3.95B | $4.57B | $5.08B |
| Low Forecast | $8.54B | $7.79B | $7.52B | $7.01B | $7.51B | $6.84B | $6.68B | $6.33B | $6.75B | $6.10B | $5.98B | $5.63B | $6.20B | $4.32B | $5.54B | $5.29B | $5.83B | $3.93B | $-69.66M | $4.76B | $4.88B | $3.57B | $4.29B | $4.10B | $4.63B | $3.51B | $4.11B | $3.86B | $4.46B | $3.39B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.62% | 1.12% | - | -78.53% | 0.85% | 1.06% | - | - | 1.00% | 1.19% | - | - | 1.00% | 1.10% | - |
Forecast
15 analysts predict ORCL's average Quarter EBITDA for Nov 23 to be $5.56B, with a high of $5.60B and a low of $5.54B. This is 68.67% upper than Oracle's previous annual EBITDA (Aug 23) of $3.30B.
Oracle Net Income Forecast
Quarter
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Nov 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 8 | 9 | 13 | 8 | 8 | 8 | 12 | 7 | 16 | 17 | 8 | 9 | 9 | 15 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 10 | 10 | 10 | 8 | 10 | 14 | 8 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.42B | $3.32B | - | $1.74B | $1.55B | $3.19B | - | - | $2.46B | $4.03B | - | - | $2.25B | $3.12B | - |
| Avg Forecast | $6.81B | $5.87B | $5.58B | $5.02B | $5.83B | $5.03B | $4.80B | $4.41B | $5.14B | $4.29B | $4.25B | $3.82B | $4.73B | $2.92B | $3.81B | $3.30B | $4.54B | $2.66B | $-1.25B | $3.06B | $3.91B | $2.42B | $3.17B | $2.77B | $3.73B | $4.79B | $2.84B | $2.45B | $3.26B | $2.54B |
| High Forecast | $6.91B | $5.95B | $5.65B | $5.08B | $5.91B | $5.09B | $4.86B | $4.47B | $5.21B | $4.44B | $4.28B | $3.82B | $4.73B | $3.51B | $3.84B | $3.35B | $4.60B | $3.19B | $-998.50M | $3.10B | $3.96B | $2.90B | $3.21B | $2.81B | $3.78B | $5.75B | $2.88B | $2.49B | $3.30B | $3.05B |
| Low Forecast | $6.78B | $5.83B | $5.55B | $4.99B | $5.80B | $5.00B | $4.77B | $4.38B | $5.11B | $4.03B | $4.14B | $3.82B | $4.73B | $2.34B | $3.78B | $3.28B | $4.51B | $2.13B | $-1.50B | $3.01B | $3.84B | $1.93B | $3.11B | $2.72B | $3.66B | $3.84B | $2.79B | $2.41B | $3.20B | $2.04B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.73% | 0.73% | - | -1.39% | 0.51% | 0.82% | - | - | 0.89% | 1.08% | - | - | 0.92% | 0.96% | - |
Forecast
Oracle's average Quarter net income forecast for Nov 23 is $3.81B, with a range of $3.78B to $3.84B. ORCL's average Quarter net income forecast represents a 57.29% increase compared to the company's last Quarter net income of $2.42B (Aug 23).
Oracle SG&A Forecast
Quarter
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Nov 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 8 | 9 | 13 | 8 | 8 | 8 | 12 | 7 | 16 | 17 | 8 | 9 | 9 | 15 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 10 | 10 | 10 | 8 | 10 | 14 | 8 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.42B | $2.69B | - | $2.58B | $2.59B | $2.60B | - | - | $2.15B | $2.38B | - | - | $2.15B | $2.24B | - |
| Avg Forecast | $4.32B | $3.94B | $3.80B | $3.55B | $3.80B | $3.46B | $3.38B | $3.20B | $3.41B | $3.09B | $3.03B | $2.84B | $3.12B | $2.95B | $2.80B | $2.68B | $2.95B | $2.68B | $2.28B | $2.43B | $2.49B | $2.44B | $2.19B | $2.09B | $2.36B | $2.14B | $2.10B | $1.97B | $2.28B | $2.31B |
| High Forecast | $4.37B | $3.98B | $3.84B | $3.58B | $3.84B | $3.50B | $3.42B | $3.23B | $3.45B | $3.11B | $3.07B | $2.84B | $3.12B | $3.54B | $2.82B | $2.70B | $2.98B | $3.22B | $2.73B | $2.45B | $2.52B | $2.93B | $2.21B | $2.11B | $2.39B | $2.57B | $2.12B | $1.99B | $2.30B | $2.78B |
| Low Forecast | $4.30B | $3.92B | $3.79B | $3.53B | $3.78B | $3.45B | $3.37B | $3.19B | $3.40B | $3.07B | $3.01B | $2.84B | $3.12B | $2.36B | $2.79B | $2.66B | $2.93B | $2.15B | $1.82B | $2.40B | $2.46B | $1.95B | $2.16B | $2.06B | $2.33B | $1.72B | $2.07B | $1.94B | $2.25B | $1.85B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.91% | - | 1.13% | 1.06% | 1.04% | - | - | 1.03% | 1.01% | - | - | 1.09% | 0.98% | - |
Forecast
Oracle's average Quarter SG&A projection for Nov 23 is $2.80B, based on 15 Wall Street analysts, with a range of $2.79B to $2.82B. The forecast indicates a 15.77% rise compared to ORCL last annual SG&A of $2.42B (Aug 23).
Oracle EPS Forecast
Quarter
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Nov 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 8 | 9 | 13 | 8 | 8 | 8 | 12 | 7 | 16 | 17 | 8 | 9 | 9 | 15 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 10 | 10 | 10 | 8 | 10 | 14 | 8 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.89 | $1.23 | - | $0.65 | $0.58 | $1.20 | - | - | $0.89 | $1.42 | - | - | $0.74 | $1.02 | - |
| Avg Forecast | $2.38 | $2.04 | $1.94 | $1.75 | $2.03 | $1.75 | $1.67 | $1.54 | $1.79 | $1.50 | $1.48 | $1.33 | $1.65 | $1.38 | $1.33 | $1.15 | $1.58 | $1.20 | $1.11 | $1.07 | $1.37 | $1.18 | $1.11 | $0.97 | $1.31 | $1.11 | $1.00 | $0.86 | $1.14 | $0.96 |
| High Forecast | $2.41 | $2.07 | $1.97 | $1.77 | $2.06 | $1.78 | $1.69 | $1.56 | $1.82 | $1.55 | $1.49 | $1.33 | $1.65 | $1.38 | $1.34 | $1.17 | $1.60 | $1.22 | $1.33 | $1.09 | $1.39 | $1.19 | $1.13 | $0.99 | $1.32 | $1.12 | $1.01 | $0.87 | $1.16 | $0.97 |
| Low Forecast | $2.36 | $2.03 | $1.93 | $1.74 | $2.02 | $1.74 | $1.66 | $1.53 | $1.78 | $1.41 | $1.44 | $1.33 | $1.65 | $1.38 | $1.32 | $1.14 | $1.57 | $1.20 | $0.89 | $1.06 | $1.35 | $1.16 | $1.09 | $0.95 | $1.28 | $1.09 | $0.98 | $0.85 | $1.12 | $0.94 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 0.78% | - | 0.59% | 0.54% | 0.88% | - | - | 0.92% | 1.09% | - | - | 0.86% | 0.90% | - |
Forecast
According to 15 Wall Street analysts, Oracle's projected average Quarter EPS for Nov 23 is $1.33, with a low estimate of $1.32 and a high estimate of $1.34. This represents a 49.07% increase compared to ORCL previous annual EPS of $0.89 (Aug 23).
Oracle Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| PANW | Palo Alto Networks | $201.24 | $400.29 | 98.91% | Buy |
| ADBE | Adobe | $455.23 | $614.25 | 34.93% | Buy |
| NTNX | Nutanix | $66.14 | $78.75 | 19.07% | Buy |
| OKTA | Okta | $85.42 | $93.38 | 9.32% | Hold |
| MSFT | Microsoft | $454.46 | $495.87 | 9.11% | Buy |
| ORCL | Oracle | $169.71 | $184.18 | 8.53% | Buy |
| ZS | Zscaler | $200.45 | $209.91 | 4.72% | Buy |
| PATH | UiPath | $13.91 | $14.50 | 4.24% | Hold |
| SQ | Block | $94.55 | $92.33 | -2.35% | Buy |
| CRWD | CrowdStrike | $376.42 | $349.42 | -7.17% | Buy |
| NET | Cloudflare | $117.56 | $89.75 | -23.66% | Hold |
| PLTR | Palantir | $74.39 | $42.17 | -43.31% | Hold |